Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2006; 12(30): 4850-4858
Published online Aug 14, 2006. doi: 10.3748/wjg.v12.i30.4850
Published online Aug 14, 2006. doi: 10.3748/wjg.v12.i30.4850
Figure 2 DA-9601 inhibits the expression and secretion of CCL20 in AGS cells.
(A) AGS cells (1 x 105) were treated with various concentrations of DA-9601 (0-100 μg/mL) for 16 h. Quantitative analysis of cell viability was determined by the MTT assay (mean ± SD., n = 3). (B) Cells (5 x 105) were pretreated with various concentrations of DA-9601 (0-100 μg/mL) for 1 h, and then the cells were further incubated for 8 h with TNF-α (5 ng/mL). Levels of IL-8 and CCL20 mRNAs were determined by RT-PCR. (C) Cells (5 x 105) were pretreated with various concentrations of DA-9601 (0-100 μg/mL) for 1 h, and then the cells were further incubated for 16 h with TNF-α (5 ng/mL). IL-8 and CCL20 protein levels were determined by ELISA. These data are representative of three independent experiments.
- Citation: Choi SC, Choi EJ, Oh HM, Lee S, Lee JK, Lee MS, Shin YI, Choi SJ, Chae JR, Lee KM, Lee WJ, Park JS, Shin CY, Oh TY, Jun CD. DA-9601, a standardized extract of Artemisia asiatica, blocks TNF-α-induced IL-8 and CCL20 production by inhibiting p38 kinase and NF-κB pathways in human gastric epithelial cells. World J Gastroenterol 2006; 12(30): 4850-4858
- URL: https://www.wjgnet.com/1007-9327/full/v12/i30/4850.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i30.4850